Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors. Its structural features enable selective binding to enzyme active sites, making it valuable in the creation of targeted therapies for cancer and inflammatory diseases. The hydroxyl and bromo-substituted pyridine groups allow for further functionalization through cross-coupling reactions, facilitating the construction of complex drug molecules. Its stereochemistry is critical for achieving high biological activity and selectivity in the final active pharmaceutical ingredient.